We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
ERSOT
226
Employees Retirement System of Texas
Texas
$89.3M -$637K -6,300 -0.7%
ICM
227
IronBridge Capital Management
Illinois
$89M +$84.5M +835,630 +5,487%
Jacobs Levy Equity Management
228
Jacobs Levy Equity Management
New Jersey
$88.7M -$2.07M -20,440 -2%
BMO
229
Beck Mack & Oliver
New York
$88.6M -$3M -29,715 -3%
GC
230
Guggenheim Capital
Illinois
$87.6M -$490K -4,848 -0.6%
NPA
231
Nichols & Pratt Advisers
Massachusetts
$85.8M -$416K -4,118 -0.5%
KFC
232
Klingenstein Fields & Co
New York
$85.7M -$398K -3,938 -0.5%
N
233
Nuveen
North Carolina
$84.1M -$806K -7,979 -1%
AI
234
Analytic Investors
California
$84M -$23.5M -232,248 -22%
CEP
235
Chicago Equity Partners
Illinois
$83.5M +$11.7M +115,665 +17%
GIBU
236
Gulf International Bank (UK)
United Kingdom
$83.2M +$512K +5,070 +0.6%
Nomura Asset Management
237
Nomura Asset Management
Japan
$83M -$34.9M -345,073 -30%
SAM
238
Shell Asset Management
Netherlands
$82.5M +$9.9M +97,953 +14%
VFA
239
Virtus Fund Advisers
Connecticut
$81.9M +$79.2M +783,232 New
RCM
240
Riverhead Capital Management
Delaware
$81.6M +$4.24M +41,996 +6%
FAF
241
Fjarde Ap-fonden
Sweden
$81.4M -$3.66M -36,212 -4%
WBC
242
Westpac Banking Corp
Australia
$81M -$14.1M -139,778 -15%
HIMCH
243
Hartford Investment Management Co (HIMCO)
Connecticut
$80.8M -$1.64M -16,266 -2%
LCS
244
Levin Capital Strategies
New York
$80.1M -$1.42M -14,040 -2%
CIC
245
Crawford Investment Counsel
Georgia
$78.1M -$2.73M -27,011 -3%
WF
246
Welch & Forbes
Massachusetts
$77.8M -$23.2K -230 -0%
IGIM
247
I.G. Investment Management
Manitoba, Canada
$76.5M -$1.81M -17,947 -2%
GH
248
GAM Holding
Switzerland
$76M -$874K -8,645 -1%
GF
249
Gabelli Funds
New York
$75.5M -$505K -5,000 -0.7%
ProShare Advisors
250
ProShare Advisors
Maryland
$75.4M -$995K -9,840 -1%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.